Brief: HBM Holdings Announces License Agreement With Windward Bio AG
Jan 10 (Reuters) - Hbm Holdings Ltd 2142.HK :
* ENTERING INTO LICENSE AGREEMENT WITH WINDWARD BIO AG
* LICENSE AGREEMENT TO GRANT WINDWARD BIO AN EXCLUSIVE
WORLDWIDE
LICENSE TO MANUFACTURE, AMONG OTHERS, HBM9378/SKB378
* LICENSE AGREEMENT EXCLUDES GREATER CHINA AND SEVERAL
SOUTHEAST
AND WEST ASIAN COUNTRIES
Further company coverage: 2142.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sichuan Kelun-Biotech Biopharmaceutical
See all newsBrief: Sichuan Kelun-Biotech Biopharmaceutical Subscribes To CZB Structured Deposit VI For RMB500 Mln
Brief: Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Accepts New Indication Application For SAC-TMT
Brief: Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results Of Skb378/Win378 In Asthma, And Initiates Phase 3 Study
China's Sichuan Kelun-Biotech swings to profit in H1 on new product approvals
Brief: Sichuan Kelun-Biotech Biopharmaceutical Posts HY Net Income Attributable Of RMB 388 MLN